Opening book details…
About this Medicine article
Response by Hänggi and Macdonald to Letter Regarding Article, “Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])” by Hänggi, Daniel; Macdonald, R. Loch is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Hänggi, Daniel; Macdonald, R. Loch
- Publisher
- Lippincott Williams and Wilkins; Ovid Technologies Wolters Kluwer -American Heart Association; Lippincott Williams & Wilkins Ltd.; Publons; Ovid Technologies (Wolters Kluwer Health) (ISSN 0039-2499)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)